专利检索 ap:("James Ronald Gillig" OR "Lawrence Joseph Heinz" OR "Michael Dean Kinnick" OR "Yen-Shi Lai" OR "John Michael Morin" OR "Nancy June Snyder") AND inv:"Yen-Shi Lai" 第 1 页

1.

发明授权
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes 失效
标题翻译：用作黑色素浓缩激素拮抗剂治疗肥胖和糖尿病的多环化合物

公开(公告)号：US07229987B2

公开(公告)日：2007-06-12

申请号：US10512986

申请日：2003-05-06

申请人： Jochen Ammenn , James Ronald Gillig , Lawrence Joseph Heinz , Philip Arthur Hipskind , Michael Dean Kinnick , Yen-Shi Lai , John Michael Morin, Jr. , James Arthur Nixon , Carsten Ott , Kenneth Allen Savin , Theo Schotten , Lawrence John Slieker , Nancy June Snyder , Michael Alan Robertson

发明人： Jochen Ammenn , James Ronald Gillig , Lawrence Joseph Heinz , Philip Arthur Hipskind , Michael Dean Kinnick , Yen-Shi Lai , John Michael Morin, Jr. , James Arthur Nixon , Carsten Ott , Kenneth Allen Savin , Theo Schotten , Lawrence John Slieker , Nancy June Snyder , Michael Alan Robertson

IPC分类号： A61K31/5355 , A61K31/454 , C07D401/12 , C07D403/12 , C07D263/32

CPC分类号： C07D249/08 , C07D261/08 , C07D263/32 , C07D271/06 , C07D271/10 , C07D271/107 , C07D277/26 , C07D333/18 , C07D413/04 , C07D413/06 , C07D413/10 , C07D413/12 , C07D413/14 , C07D417/12

摘要： The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.

摘要翻译： 本发明涉及式I的黑色素浓缩激素拮抗剂化合物：（I）; 或其药学上可接受的盐，溶剂化物，对映异构体或前药，用于治疗，预防或改善与肥胖症和相关疾病相关的症状。

2.

发明授权
MCH receptor antagonists 失效
标题翻译： MCH受体拮抗剂

公开(公告)号：US07132456B2

公开(公告)日：2006-11-07

申请号：US10536053

申请日：2003-12-03

申请人： James Ronald Gillig , Lawrence Joseph Heinz , Michael Dean Kinnick , Yen-Shi Lai , John Michael Morin , Nancy June Snyder

发明人： James Ronald Gillig , Lawrence Joseph Heinz , Michael Dean Kinnick , Yen-Shi Lai , John Michael Morin , Nancy June Snyder

IPC分类号： A61K31/165 , C07C55/06 , C07C323/42

CPC分类号： C07C323/60

摘要： The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar1, Ar2, Ar3, L1, L2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases

摘要翻译： 本发明涉及式I的黑色素浓缩激素拮抗剂化合物：（I）其中Ar 1，Ar 2，Ar 3，L 限定的1个或2个Q区域，或其可用于治疗，预防或改善与肥胖有关的症状的非对映异构体的药学上可接受的盐，溶剂合物，对映异构体或混合物和相关疾病

3.

发明申请
Novel mch receptor antagonists 失效
标题翻译：新型mch受体拮抗剂

公开(公告)号：US20060052449A1

公开(公告)日：2006-03-09

申请号：US10536053

申请日：2003-12-03

申请人： James Gillig , Lawrence Heinz , Michael Kinnick , Yen-Shi Lai , John Morin , Nancy Snyder

发明人： James Gillig , Lawrence Heinz , Michael Kinnick , Yen-Shi Lai , John Morin , Nancy Snyder

IPC分类号： A61K31/205 , C07C323/39

CPC分类号： C07C323/60

摘要： The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar1, Ar2, Ar3, L1, L2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.

摘要翻译： 本发明涉及式I的黑色素浓缩激素拮抗剂化合物：（I）其中Ar 1，Ar 2，Ar 3，L 限定的1个或2个Q区域，或其可用于治疗，预防或改善与肥胖有关的症状的非对映异构体的药学上可接受的盐，溶剂合物，对映异构体或混合物和相关疾病